Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shenqi Xinshu Capsules (参七心疏胶囊) is a proprietary traditional Chinese medicine (TCM) manufactured by Yunnan Yongzitang, a subsidiary of Hunan Hansen Pharmaceutical. It is an approved oral herbal formulation provided in capsule form. As a traditional medicine, its therapeutic effects are based on holistic herbal combinations rather than a single molecular target. The formulation typically contains ingredients like Panax notoginseng (Sanqi) and potentially Ginseng (Renshen) or Codonopsis (Dangshen), which are traditionally used in China to promote blood circulation, resolve blood stasis, and manage cardiovascular symptoms such as chest pain or palpitations associated with coronary heart disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shenqi Xinshu Capsules.